VIVUS 3.75/23 (Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg)

Generic Name: phentermine/topiramate

Pill imprint VIVUS 3.75/23 has been identified as Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg.

Qsymia is used in the treatment of weight loss; obesity and belongs to the drug class anorexiants. Not for use in pregnancy. Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Imprint Search

Images for VIVUS 3.75/23

Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg VIVUS 3.75/23
Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg VIVUS 3.75/23
Qsymia
Generic Name:
phentermine/topiramate
Imprint:
VIVUS
3.75/23
Strength:
phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Anorexiants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Vivus, Inc.
National Drug Code (NDC):
62541-0201
Inactive Ingredients:
sucrose
corn starch
microcrystalline cellulose
ethylcelluloses
povidone k30
gelatin
magnesium silicate
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3

Submitted by: pillstress

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)